CDE Detailed Report
Disease: content
Subdomain Name: Functional Outcomes
CRF: welcome
Displaying 1 - 1 of 1
Subdomain Name: Functional Outcomes
CRF: welcome
Displaying 1 - 1 of 1
| CDE ID | CDE Name | Variable Name | Definition | Short Description | Question Text | Permissible Values | Description | Data Type | Disease Specific Instructions | Disease Specific Reference | Population | Classification (e.g., Core) | Version Number | Version Date | CRF Name (CRF Module / Guidance) | Subdomain Name | Domain Name | Size | Input Restrictions | Min Value | Max Value | Measurement Type | External Id Loinc | External Id Snomed | External Id caDSR | External Id CDISC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C21726 | Karnofsky modified performance status score | KarnModPerfStScore | Score identifying current level of functioning favoring the highest level estimate | Score identifying current level of functioning favoring the highest level estimat | Modified Karnofsky Score | 100;90;80;70;60;50;40;30;20;10 | I feel normal: No complaints. No evidence of disease;I am able to carry on normal activity, with minor symptoms;I carry on normal activity with effort and some symptoms;I am able to care for myself, but unable to carry on normal activities;I require occasional assistance, but can care for most of my needs;I require considerable assistance and frequent care by others;I am disabled. I require considerable assistance and frequent care by others;I am severely disabled. I am hospitalized, but death is not imminent;I am very sick. I require active supportive care by others;I have fatal processes that are rapidly progressing. I am near death | Alphanumeric | Karnofsky DA, Burchenal JH, Armistead GC, Southam CM, Bernstein JL, Craver LF, Rhoads CP. Triethylene melamine in the treatment of neoplastic disease. Arch Intern Med.1951;87:477–516, 1951. | Adult | Supplemental | 1.00 | 2016-06-01 09:59:36.0 | Functional Status Karnofsky Score | Functional Outcomes | Outcomes and End Points |
Single Pre-Defined Value Selected |
